These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 26849232)

  • 21. GRIK2 has a role in the maintenance of urothelial carcinoma stem-like cells, and its expression is associated with poorer prognosis.
    Inoue R; Hirohashi Y; Kitamura H; Nishida S; Murai A; Takaya A; Yamamoto E; Matsuki M; Tanaka T; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Sato N; Masumori N; Torigoe T
    Oncotarget; 2017 Apr; 8(17):28826-28839. PubMed ID: 28418868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of BORIS/CTCFL efficiently regulates cancer stemness and metastasis in MYCN amplified neuroblastoma cell line by modulating Wnt/β-catenin signaling pathway.
    Garikapati KR; Patel N; Makani VKK; Cilamkoti P; Bhadra U; Bhadra MP
    Biochem Biophys Res Commun; 2017 Feb; 484(1):93-99. PubMed ID: 28104398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible role of mural cell-covered mature blood vessels in inducing drug resistance in cancer-initiating cells.
    Matsui T; Kinugasa Y; Tahara H; Kanakura Y; Takakura N
    Am J Pathol; 2013 May; 182(5):1790-9. PubMed ID: 23473746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate cancer stem-like cells/cancer-initiating cells have an autocrine system of hepatocyte growth factor.
    Nishida S; Hirohashi Y; Torigoe T; Inoue R; Kitamura H; Tanaka T; Takahashi A; Asanuma H; Masumori N; Tsukamoto T; Sato N
    Cancer Sci; 2013 Apr; 104(4):431-6. PubMed ID: 23320511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling.
    Wu MJ; Jan CI; Tsay YG; Yu YH; Huang CY; Lin SC; Liu CJ; Chen YS; Lo JF; Yu CC
    Mol Cancer; 2010 Oct; 9():283. PubMed ID: 20979610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers.
    Lo JF; Yu CC; Chiou SH; Huang CY; Jan CI; Lin SC; Liu CJ; Hu WY; Yu YH
    Cancer Res; 2011 Mar; 71(5):1912-23. PubMed ID: 21169409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BORIS and CTCF are overexpressed in squamous intraepithelial lesions and cervical cancer.
    Velázquez-Hernández N; Reyes-Romero MA; Barragán-Hernández M; Guerrero-Romero F; Rodríguez-Moran M; Aguilar-Durán M; Lazalde Medina B
    Genet Mol Res; 2015 Jun; 14(2):6094-100. PubMed ID: 26125810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer stem cells (CSCs), cervical CSCs and targeted therapies.
    Huang R; Rofstad EK
    Oncotarget; 2017 May; 8(21):35351-35367. PubMed ID: 27343550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance.
    López J; Poitevin A; Mendoza-Martínez V; Pérez-Plasencia C; García-Carrancá A
    BMC Cancer; 2012 Jan; 12():48. PubMed ID: 22284662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo imaging, tracking, and targeting of cancer stem cells.
    Vlashi E; Kim K; Lagadec C; Donna LD; McDonald JT; Eghbali M; Sayre JW; Stefani E; McBride W; Pajonk F
    J Natl Cancer Inst; 2009 Mar; 101(5):350-9. PubMed ID: 19244169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA methyltransferase 1 is essential for initiation of the colon cancers.
    Morita R; Hirohashi Y; Suzuki H; Takahashi A; Tamura Y; Kanaseki T; Asanuma H; Inoda S; Kondo T; Hashino S; Hasegawa T; Tokino T; Toyota M; Asaka M; Torigoe T; Sato N
    Exp Mol Pathol; 2013 Apr; 94(2):322-9. PubMed ID: 23064049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Therapeutic Vaccine Targeting Rat BORIS (CTCFL) for the Treatment of Rat Breast Cancer Tumors.
    Loukinov D; Anderson AL; Mkrtichyan M; Ghochikyan A; Rivero-Hinojosa S; Tucker J; Lobanenkov V; Agadjanyan MG; Nelson EL
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of Gremlin 1 in cervical cancer and its effects on cancer stem cell maintenance.
    Sato M; Kawana K; Fujimoto A; Yoshida M; Nakamura H; Nishida H; Inoue T; Taguchi A; Takahashi J; Adachi K; Nagasaka K; Matsumoto Y; Wada-Hiraike O; Oda K; Osuga Y; Fujii T
    Oncol Rep; 2016 Jan; 35(1):391-7. PubMed ID: 26530461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Cross Talk between Cancer Stem Cells/Cancer Initiating Cells and Tumor Microenvironment: The Missing Piece of the Puzzle for the Efficient Targeting of these Cells with Immunotherapy.
    Ravindran S; Rasool S; Maccalli C
    Cancer Microenviron; 2019 Dec; 12(2-3):133-148. PubMed ID: 31758404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer.
    Miyamoto S; Kochin V; Kanaseki T; Hongo A; Tokita S; Kikuchi Y; Takaya A; Hirohashi Y; Tsukahara T; Terui T; Ishitani K; Hata F; Takemasa I; Miyazaki A; Hiratsuka H; Sato N; Torigoe T
    Cancer Immunol Res; 2018 Mar; 6(3):358-369. PubMed ID: 29371260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.
    Ma L; Lai D; Liu T; Cheng W; Guo L
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):593-602. PubMed ID: 20705681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression of hTERT and stemness genes in BORIS/CTCFL positive cells isolated from embryonic cancer cells.
    Alberti L; Renaud S; Losi L; Leyvraz S; Benhattar J
    PLoS One; 2014; 9(10):e109921. PubMed ID: 25279549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visualization and characterization of cancer stem-like cells in cervical cancer.
    Hayashi K; Tamari K; Ishii H; Konno M; Nishida N; Kawamoto K; Koseki J; Fukusumi T; Kano Y; Nishikawa S; Miyo M; Noguchi K; Ogawa H; Hamabe A; Seo Y; Doki Y; Mori M; Ogawa K
    Int J Oncol; 2014 Dec; 45(6):2468-74. PubMed ID: 25269542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor efficacy of DNA vaccination to the epigenetically acting tumor promoting transcription factor BORIS and CD80 molecular adjuvant.
    Loukinov D; Ghochikyan A; Mkrtichyan M; Ichim TE; Lobanenkov VV; Cribbs DH; Agadjanyan MG
    J Cell Biochem; 2006 Aug; 98(5):1037-43. PubMed ID: 16741971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment and evaluation of cell and animal models expressing BORIS subfamily 2 variant.
    Qin L; Liu ZJ; Xian LJ; Hu L; Fu Q; Chen LH; Qin Y
    Ann Transl Med; 2022 Jun; 10(11):632. PubMed ID: 35813346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.